329 related articles for article (PubMed ID: 25312503)
1. GLT-1 transporter: an effective pharmacological target for various neurological disorders.
Soni N; Reddy BV; Kumar P
Pharmacol Biochem Behav; 2014 Dec; 127():70-81. PubMed ID: 25312503
[TBL] [Abstract][Full Text] [Related]
2. The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.
Pajarillo E; Rizor A; Lee J; Aschner M; Lee E
Neuropharmacology; 2019 Dec; 161():107559. PubMed ID: 30851309
[TBL] [Abstract][Full Text] [Related]
3. Current approaches to enhance glutamate transporter function and expression.
Fontana AC
J Neurochem; 2015 Sep; 134(6):982-1007. PubMed ID: 26096891
[TBL] [Abstract][Full Text] [Related]
4. The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes.
Bridges RJ; Esslinger CS
Pharmacol Ther; 2005 Sep; 107(3):271-85. PubMed ID: 16112332
[TBL] [Abstract][Full Text] [Related]
5. Role of the GLT-1 subtype of glutamate transporter in glutamate homeostasis: the GLT-1-preferring inhibitor WAY-855 produces marginal neurotoxicity in the rat hippocampus.
Selkirk JV; Nottebaum LM; Vana AM; Verge GM; Mackay KB; Stiefel TH; Naeve GS; Pomeroy JE; Petroski RE; Moyer J; Dunlop J; Foster AC
Eur J Neurosci; 2005 Jun; 21(12):3217-28. PubMed ID: 16026460
[TBL] [Abstract][Full Text] [Related]
6. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
[TBL] [Abstract][Full Text] [Related]
7. Excitatory amino acid transporters: a family in flux.
Seal RP; Amara SG
Annu Rev Pharmacol Toxicol; 1999; 39():431-56. PubMed ID: 10331091
[TBL] [Abstract][Full Text] [Related]
8. Abnormal expressions of glutamate transporters and metabotropic glutamate receptor 1 in the spontaneously epileptic rat hippocampus.
Guo F; Sun F; Yu JL; Wang QH; Tu DY; Mao XY; Liu R; Wu KC; Xie N; Hao LY; Cai JQ
Brain Res Bull; 2010 Mar; 81(4-5):510-6. PubMed ID: 19853022
[TBL] [Abstract][Full Text] [Related]
9. Acute regulation of sodium-dependent glutamate transporters: a focus on constitutive and regulated trafficking.
Robinson MB
Handb Exp Pharmacol; 2006; (175):251-75. PubMed ID: 16722240
[TBL] [Abstract][Full Text] [Related]
10. GLT-1 Upregulation as a Potential Therapeutic Target for Ischemic Brain Injury.
Hu YY; Li L; Xian XH; Zhang M; Sun XC; Li SQ; Cui X; Qi J; Li WB
Curr Pharm Des; 2017; 23(33):5045-5055. PubMed ID: 28641538
[TBL] [Abstract][Full Text] [Related]
11. Glutamate-based therapeutic approaches: targeting the glutamate transport system.
Dunlop J
Curr Opin Pharmacol; 2006 Feb; 6(1):103-7. PubMed ID: 16368269
[TBL] [Abstract][Full Text] [Related]
12. Molecular pharmacology of glutamate transporters, EAATs and VGLUTs.
Shigeri Y; Seal RP; Shimamoto K
Brain Res Brain Res Rev; 2004 Jul; 45(3):250-65. PubMed ID: 15210307
[TBL] [Abstract][Full Text] [Related]
13. Subcellular localization of the glutamate transporters GLAST and GLT at the neuromuscular junction in rodents.
Rinholm JE; Slettaløkken G; Marcaggi P; Skare Ø; Storm-Mathisen J; Bergersen LH
Neuroscience; 2007 Mar; 145(2):579-91. PubMed ID: 17289278
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury.
Verma R; Mishra V; Sasmal D; Raghubir R
Eur J Pharmacol; 2010 Jul; 638(1-3):65-71. PubMed ID: 20423712
[TBL] [Abstract][Full Text] [Related]
15. Suppressive effects of intrathecal granulocyte colony-stimulating factor on excessive release of excitatory amino acids in the spinal cerebrospinal fluid of rats with cord ischemia: role of glutamate transporters.
Chen WF; Sung CS; Jean YH; Su TM; Wang HC; Ho JT; Huang SY; Lin CS; Wen ZH
Neuroscience; 2010 Feb; 165(4):1217-32. PubMed ID: 19932886
[TBL] [Abstract][Full Text] [Related]
16. Decrease in glial glutamate transporter variants and excitatory amino acid receptor down-regulation in a murine model of ALS-PDC.
Wilson JM; Khabazian I; Pow DV; Craig UK; Shaw CA
Neuromolecular Med; 2003; 3(2):105-18. PubMed ID: 12728193
[TBL] [Abstract][Full Text] [Related]
17. Expression of glutamate transporters GLT-1 and GLAST in different regions of rat brain during the course of experimental autoimmune encephalomyelitis.
Mitosek-Szewczyk K; Sulkowski G; Stelmasiak Z; Struzyńska L
Neuroscience; 2008 Jul; 155(1):45-52. PubMed ID: 18572325
[TBL] [Abstract][Full Text] [Related]
18. Functional expression of particular isoforms of excitatory amino acid transporters by rodent cartilage.
Hinoi E; Wang L; Takemori A; Yoneda Y
Biochem Pharmacol; 2005 Jul; 70(1):70-81. PubMed ID: 15894296
[TBL] [Abstract][Full Text] [Related]
19. Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.
Takahashi K; Foster JB; Lin CL
Cell Mol Life Sci; 2015 Sep; 72(18):3489-506. PubMed ID: 26033496
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of brain-enriched miR-107 promotes excitatory neurotoxicity through down-regulation of glutamate transporter-1 expression following ischaemic stroke.
Yang ZB; Zhang Z; Li TB; Lou Z; Li SY; Yang H; Yang J; Luo XJ; Peng J
Clin Sci (Lond); 2014 Dec; 127(12):679-89. PubMed ID: 24943094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
